All formulations in the trial led to "clinically meaningful" improvements in pain after just 4 weeks.
A top professor at The Hebrew University of Jerusalem believes the CBD formulation holds "immense potential".
The latest scientific papers exploring cannabis and its impact on health and society.
Eurocan explores how ongoing research into cannabinoids can help understand their therapeutic potential
Andrew Megahy, lead science officer at Always Pure Organics, explains more about CBDA and CBGA.
Do males and females respond to cannabis differently? Not according to a new study from researchers in Australia.
Almost 4,000 scientific research papers were published on cannabis this year.
An expert explains everything you need to know about the clinical trials taking place on cannabinoids.
Ever wondered what the deal is with the endocannabinoid system? Registered Pharmacist Dr Monica Taing explains.
EuroCan’s chief technical officer, Miguel Fagundes shares his insight on the process.